Mastitis is an inflammatory condition of the breast, which may or may not be accompanied by infection. It affects 10-33% of breastfeeding mothers and is a key barrier to continue breastfeeding.

A new study shows that supplementation of the probiotic strain Ligilactobacillus salivarius PS2 during late pregnancy and early lactation is safe and effective in preventing mastitis. The findings indicate that women in the probiotic group were 58% were less likely to develop mastitis.

This article is reused from: Jimenez, E., Manzano, S., Schlembach, D., Arciszewski, K., Martin, R., Ben Amor, K., Roelofs, M., Knol, J., Rodriguez, J. M., and Abou-Dakn, M. Ligilactobacillus salivarius ps2 supplementation during pregnancy and lactation prevents mastitis: A randomised controlled trial. Microorganisms 2021, 9(9), 1933. No changes were made to this article.